Cardiac sarcoidosis a pathology-focused review

Archives of Pathology and Laboratory Medicine

Volumn 134, Issue 7, 2010, Pages 1039-1046

  Lagana, Stephen M ^a   Parwani, Anil V ^b   Nichols, Larry C ^b  

^a NewYork Presbyterian Hospital   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOMYOPATHY; DIFFERENTIAL DIAGNOSIS; GRANULOMA; HEART DISEASE; HUMAN; PATHOLOGY; REVIEW; SARCOIDOSIS;

CARDIOMYOPATHIES; DIAGNOSIS, DIFFERENTIAL; GRANULOMA; HEART DISEASES; HUMANS; SARCOIDOSIS;

EID: 77954339032     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Review

References (70)

1. Sharma OP. Sarcoidosis: a historical perspective. Clin Dermatol. 2007;25(3):232-241.
2. Hutchinson J. Cases of Mortimer's malady, a form of lupus pernio. Arch Surg. 1898;9:307-315.
3. Longcope WT, Freiman DG. A study of sarcoidosis; based on a combined investigation of 160 cases including 30 autopsies from The Johns Hopkins Hospital and Massachusetts General Hospital. Medicine (Baltimore). 1952;31(1):1-132.
4. Bernstein M, Konzelman FW, Sidlick DM. Boeck's sarcoid: report of a case with visceral involvement. Arch Intern Med. 1929;4:721-734.
5. Chapelon-Abric C, de Zuttere D, Duhaut P, et al. Cardiac sarcoidosis: a retrospective study of 41 cases. Medicine (Baltimore). 2004;83(6):315-334.
6. Iwai K, Tachibana T, Takemura T, Matsui Y, Kitaichi M, Kawabata Y. Pathological studies on sarcoidosis autopsy: I. epidemiological features of 320 cases in Japan. Acta Pathol Jpn. 1993;43(7-8): 372-376.
7. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med. 1999;160(2):736-755.
8. Costabel U, Hunninghake GW. ATS/ERS/WASOG statement on sarcoidosis: Sarcoidosis Statement Committee, American Thoracic Society, European Respiratory Society, World Association for Sarcoidosis and Other Granulomatous Disorders. Eur Respir J. 1999;14(4):735-737.
9. Rybicki BA, Iannuzzi MC. Epidemiology of sarcoidosis: recent advances and future prospects. Semin Respir Crit Care Med. 2007;28(1):22-35.
10. Doughan AR, Williams BR. Cardiac sarcoidosis. Heart. 2006;92(2):282-288.
11. Newman LS, Rose CS, Maier LA. Sarcoidosis. N Engl J Med. 1997;336(17):1224-1234.
12. Mehta D, Lubitz SA, Frankel Z, et al. Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing. Chest. 2008;133(6):1426-1435.
13. Silverman KJ, Hutchins GM, Bulkley BH. Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation. 1978;58(6):1204-1211.
14. Fabre A, Sheppard, MN. Sudden adult death syndrome and other nonischaemic causes of sudden cardiac death. Heart. 2006;92:316-320.
15. Martin WJ, Iannuzzi MC, Gail DB, Peavy HH. Future directions in sarcoidosis research: summary of an NHLBI working group. Am J Respir Crit Care Med. 2004;170(5):567-571.
16. Takashige N, Naruse TK, Matsumori A, et al. Genetic polymorphisms at the tumour necrosis factor loci (TNFA and TNFB) in cardiac sarcoidosis. Tissue Antigens. 1999;54(2):191-193.
17. Semenzato G. ACCESS: a case control etiologic study of sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2005;22(2):83-86.
18. Rybicki BA, Iannuzzi MC, Frederick MM, et al. Familial aggregation of sarcoidosis: a case-control etiologic study of sarcoidosis (ACCESS). Am J Respir Crit Care Med. 2001;164(11):2085-2091.
19. Heffner DK. The cause of sarcoidosis: the centurial enigma solved. Ann Diagn Pathol. 2007;11(2):142-152.
20. Ezzie ME, Crouser ED. Considering an infectious etiology of sarcoidosis. Clin Dermatol. 2007;25(3):259-266.
21. Chen ES, Moller DR. Etiology of sarcoidosis. Clin Chest Med. 2008;29(3):365-377.
22. Abul Y, Abul MH, Silay MS, Silay YS. The role of nanobacteria in cardiac sarcoidosis. Med Hypotheses. 2007;68(5):1180.
23. Tercelj M, Rott T, Rylander R. Antifungal treatment in sarcoidosis-a pilot intervention trial. Respir Med. 2007;101(4):774-778.
24. Sapadin AN, Fleischmajer R. Tetracyclines: nonantibiotic properties and their clinical implications. J Am Acad Dermatol. 2006;54(2):258-265.
25. Judson MA, Hirst K, Iyengar SK, et al. SAGA Study Consortium: comparison of sarcoidosis phenotypes among affected African-American siblings. Chest. 2006;130(3):855-862.
26. Kreider ME, Christie JD, Thompson B, et al. Relationship of environmental exposures to the clinical phenotype of sarcoidosis. Chest. 2005;128(1):207-215.
27. Oni AA, Hershberger RE, Norman DJ, et al. Recurrence of sarcoidosis in a cardiac allograft: control with augmented corticosteroids. J Heart Lung Transplant. 1992;11(2, pt 1):367-369.
28. Yager JE, Hernandez AF, Steenbergen C, et al. Recurrence of cardiac sarcoidosis in a heart transplant recipient. J Heart Lung Transplant. 2005;24(11):1988-1990.
29. Burke WM, Keogh A, Maloney PJ, Delprado W, Bryant DH, Spratt P. Transmission of sarcoidosis via cardiac transplantation. Lancet. 1990;336:1579.
30. Reich, JM. What is sarcoidosis? Chest. 2003;124(1):367-371.
31. Moller DR, Forman JD, Liu MC, et al. Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosis. J Immunol. 1996;156(12):4952-4960.
32. Moller DR. Cells and cytokines involved in the pathogenesis of sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 1999;16(1):24-31.
33. Schoppet M, Pankuweit S, Maisch B. Cardiac sarcoidosis cytokine patterns in the course of the disease. Arch Pathol Lab Med. 2003;127:1207-1210.
34. Wahlström J, Katchar K, Wigzell H, et al. Analysis of intracellular cytokines in CD4+ and CD8+ lung and blood T cells in sarcoidosis. Am J Respir Crit Care Med. 2001;163:115-121.
35. Smedema JP, Snoep G, van Kroonenburgh MP, et al. Cardiac involvement in patients with pulmonary sarcoidosis assessed at two university medical centers in the Netherlands. Chest. 2005;128(1):30-35.
36. Roberts WC, McAllister HA, Ferrans VJ. Sarcoidosis of the heart. Am J Med. 1977;63:86-108.
37. Abrishami B, O'Connel C, Sharma O. Cardiac sarcoidosis with presentation of large left atrial mass. Curr Opin Pulm Med. 2004;10(5):397-400.
38. Perry A, Vuitch F. Causes of death in patients with sarcoidosis: a morphologic study of 38 autopsies with clinicopathologic correlations. Arch Pathol Lab Med. 1995;119(2):167-172.
39. Otsuka K, Terasaki F, Eishi Y, et al. Cardiac sarcoidosis underlies idiopathic dilated cardiomyopathy: importance of mediastinal lymphadenopathy in differential diagnosis. Circ J. 2007;71(12):1937-1941.
40. Yazaki Y, Isobe M, Hiramitsu S, et al. Comparison of clinical features and prognosis of cardiac sarcoidosis and idiopathic dilated cardiomyopathy. Am J Cardiol. 1998;82(4):537-540.
41. Yotsumoto H. Fever, hypercalcemia and tuberculosis. Intern Med. 2007;46(6):259-260.
42. Shigehara K, Shijubo N, Ohmichi M, et al. Increased circulating interleukin-12 (IL-12) p40 in pulmonary sarcoidosis. Clin Exp Immunol. 2003;132(1):152-157.
43. Fuse K, Kodama M, Okura Y, et al. Levels of serum interleukin-10 reflect disease activity in patients with cardiac sarcoidosis. Jpn Circ J. 2000;64(10):755-759.
44. Terasaki F, Ukimura A, Tsukada B, et al. Enhanced expression of type 1 helper T-cell cytokines in the myocardium of active cardiac sarcoidosis. Circ J. 2008;72(8):1303-1307.
45. Terasaki F, Fujita M, Shimomura H, et al. Enhanced expression of myeloidrelated protein complex (MRP8/14) in macrophages and multinucleated giant cells in granulomas of patients with active cardiac sarcoidosis. Circ J. 2007;71(10):1545-1550.
46. Dubrey S, Bell A, Mittal K. Sarcoid heart disease. Postgrad Med J. 2007;83:618-623.
47. Gal AA, Koss MN. The pathology of sarcoidosis. Curr Opin Pulmonary Med. 2002;8:445-451.
48. Rosen Y. Pathology of sarcoidosis. Semin Respir Crit Care Med. 2007;28(1):36-52.
49. Ishak K. Sarcoidosis of the liver and bile ducts. Mayo Clin Proc. 1998;73(5):467-472.
50. Hsu RM, Connors AF, Tomashefski JF. Histologic, microbiologic, and clinical correlates of the diagnosis of sarcoidosis by transbronchial biopsy. Arch Pathol Lab Med. 1996;120(4):364-368.
51. Jones Williams W. The nature and origin of Schaumann bodies. J Pathol Bacteriol. 1960;79:193-201.
52. Ricker W, Clark M. Sarcoidosis: a clinicopathologic review of 330 cases, including 22 autopsies. Am J Clin Pathol. 1949;19:725-749.
53. Uemura A, Morimoto S, Hiramitsu S, Kato Y, Ito T, Hishida H. Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies. Am Heart J. 1999;138:299-302.
54. Ardehali H, Howard DL, Hariri A, et al. A positive endomyocardial biopsy result for sarcoid is associated with poor prognosis in patients with initially unexplained cardiomyopathy. Am Heart J. 2005;150(3):459-463.
55. Ratner SJ, Fenoglio JJ, Ursell PC. Utility of endomyocardial biopsy in the diagnosis of cardiac sarcoidosis. Chest. 1986;90(4):528-533.
56. Okura Y, Dec. GW, Hare JM, et al. A clinical and histopathologic comparison of cardiac sarcoidosis and idiopathic giant cell myocarditis. J Am Coll Cardiol. 2003;41(2):322-329.
57. Litovsky SH, Burke AP, Virmani R. Giant cell myocarditis: an entity distinct from sarcoidosis characterized by multiphasic myocyte destruction by cytotoxic T cells and histiocytic giant cells. Mod Pathol. 1996;9(12):1126-1134.
58. Rose AG. Cardiac tuberculosis: a study of 19 patients. Arch Pathol Lab Med. 1987;111:422-426.
59. Silingardi E, Rivasi F, Santunione AL, Garagnani L. Sudden death from tubercular myocarditis. J Forensic Sci. 2006;51:667-669.
60. Jones I, Nassau E, Smith P. Cryptococcosis of the heart. Br Heart J. 1965;27:462-464.
61. Reingold IM. Myocardial lesions in disseminated coccidioidomycosis. Am J Clin Pathol. 1950;20:1044-1049.
62. Southern JF, Moscicki RA, Magro C, et al. Lymphedema, lymphocytic myocarditis and sarcoidlike granulomatosis: manifestations of Whipple's disease. JAMA. 1989;261:1467-1470.
63. Mooney EE, Kenan DJ, Sweeney EC, Gaede JT. Myocarditis in Whipple's disease: an unsuspected cause of symptoms and sudden death. Mod Pathol. 1997;10:524-529.
64. Bulkley BH, Roberts WC. The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy: a study of 36 necropsy patients. Am J Med. 1975;58:243-264.
65. Ferrans VJ, Rodriguez ER, McAllister HA Jr. Granulomatous inflammation of the heart. Heart Vessels Suppl. 1985;1:262-270.
66. Reimer KA, Rodgers RF, Oyasu R. Rheumatoid arthritis with rheumatoid heart disease and granulomatous aortitis. JAMA. 1976;23:2510-2512.
67. Takeda N, Takahashi T, Seko Y, et al. Takayasu myocarditis mediated by cytotoxic T lymphocytes. Intern Med. 2005;44:256-260.
68. Weidhase A, Grone HJ, Unterberg C, Schuff-Werner P, Weigand V. Severe granulomatous giant cell myocarditis in Wegener's granulomatosis. Klinische Wochenschrift. 1990;68:880-885.
69. Soscia JL, Fusco JM, Grace WJ. Complete heart block due to a solitary gumma. Am J Cardiol. 1964;13:553-557.
70. Loeffler AG, Memoli VA. Myocardial involvement in Erdheim-Chester disease. Arch Pathol Lab Med. 2004;128:682-685.